Invention Grant
US07863456B2 Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid
有权
结晶形式的3- [5-（2-氟苯基） - [1,2,4]恶二唑-3-基] - 苯甲酸
![Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid](/docs/US/2011-01-04/US07863456B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid
- Patent Title (中): 结晶形式的3- [5-（2-氟苯基） - [1,2,4]恶二唑-3-基] - 苯甲酸
-
Application No.: US11904005Application Date: 2007-09-24
-
Publication No.: US07863456B2Publication Date: 2011-01-04
- Inventor: Neil G. Almstead , Peter Seongwoo Hwang , Young-Choon Moon
- Applicant: Neil G. Almstead , Peter Seongwoo Hwang , Young-Choon Moon
- Applicant Address: US NJ South Plainfield
- Assignee: PTC Therapeutics, Inc.
- Current Assignee: PTC Therapeutics, Inc.
- Current Assignee Address: US NJ South Plainfield
- Agency: Jones Day
- Main IPC: C07D271/06
- IPC: C07D271/06
![Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid](/abs-image/US/2011/01/04/US07863456B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay.
Public/Granted literature
- US20080171377A1 Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid Public/Granted day:2008-07-17
Information query
